论文信息 - Reply to Michael Staehler's Letter to the Editor re: Pierre I Karakiewicz, Nazareno Suardi, Claudio Jeldres, et al. Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi. Eur Urol 2008;53:845-848 - 字舞流文

Reply to Michael Staehler's Letter to the Editor re: Pierre I Karakiewicz, Nazareno Suardi, Claudio Jeldres, et al. Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi. Eur Urol 2008;53:845-848

J. Patard | U. Capitanio | P. Karakiewicz | C. Jeldres | P. Perrotte | N. Suardi

[1] J. Patard,et al. Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma. , 2008, European urology.

[2] J. Patard,et al. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. , 2008, European urology.

[3] F. Saad,et al. Sunitinib relieves renal cell carcinoma spinal cord compression. , 2007, European urology.

[4] P. Verhagen. Re: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. , 2007, European urology.

[5] C. Wood. Multimodal Approaches in the Management of Locally Advanced and Metastatic Renal Cell Carcinoma: Combining Surgery and Systemic Therapies to Improve Patient Outcome , 2007, Clinical Cancer Research.